Klara is stepping down from The UAEM Podcast, but fear not! Please welcome Debbie, your new host.

Tahir Amin is Co-Founder and Co-Executive Director of I-MAK, a team of lawyers, scientists, and health experts who are challenging systemic injustice and advocating for health equity in drug development and access. Klara chats with Tahir about the World Trade Organization's TRIPS Waiver, the drug patenting process, 28 USC § 1498, health inequity along lines of race and class, and how the battle between modern economic ideologies affect drug pricing and health reform.

Rachel Sachs, an associate professor of Law at Washington University in St. Louis, discusses with Klara the issued Emergency Use Authorizations (EUAs) on COVID-19 therapeutics and vaccines, President Trump's Most-Favored Nation Drug Pricing Rule and rebate rule, and 2021 prescription drug pricing policy at the state and federal levels.

Expert health services researcher Dr. Stacie Dusetzina discusses how a $400 drug really costs $12, Biden's healthcare plan, bipartisan bill proposals, capping out-of-pocket costs, international reference pricing, value-based pricing, and how the COVID-19 vaccine will transform future drug pricing with Klara.

Vanderbilt professor Dr. Gilbert Gonzales discusses the ACA, disparities caused by COVID-19, future of LGBT rights, and strategies for the upcoming Biden administration with Klara.

Hosted by Klara Lou. Conversations with health policy scholars, experts, and leaders about the health care issues today in the United States.